Literature DB >> 20813527

Synthesis, antimicrobial, and mosquito larvicidal activity of 1-aryl-4-methyl-3,6-bis-(5-methylisoxazol-3-yl)-2-thioxo-2,3,6,10b-tetrahydro-1H-pyrimido[5,4-c]quinolin-5-ones.

E Rajanarendar1, M Nagi Reddy, K Rama Murthy, K Govardhan Reddy, S Raju, M Srinivas, B Praveen, M Srinivasa Rao.   

Abstract

A series of 1-aryl-4-methyl-3,6-bis-(5-methylisoxazol-3-yl)-2-thioxo-2,3,6,10b-tetrahydro-1H-pyrimido[5,4-c]quinolin-5-ones (6a-h) have been synthesized by cyclization of ethyl-3-aryl-4-(2-chlorophenyl)-6-methyl-1-(5-methylisoxazol-3-yl)-2-thioxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates 4a-h with 3-amino-5-methylisoxazole 5. Compounds 4a-h were obtained by Biginelli reaction, by condensation of aromatic aldehyde 1, ethyl acetoacetate 2, and isoxazolyl thioureas 3 in a one-pot reaction catalyzed by ceric ammonium nitrite (CAN). Compounds 6a-h were tested for their antibacterial and antifungal activities against various bacterial and fungal strains. The results showed that these compounds exhibited good antibacterial and antifungal activity compared with that of standard antibiotics. Mosquito larvicidal activity of the newly synthesized compounds 6a-h is also studied against fourth instar larvae Culex quinquefasciatus. Some of the compounds are proved to be lethal for mosquito larvae.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20813527     DOI: 10.1016/j.bmcl.2010.08.060

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  One-pot synthesis, X-ray crystal structure, and identification of potential molecules against COVID-19 main protease through structure-guided modeling and simulation approach.

Authors:  Youness El Bakri; Malahat Musrat Kurbanova; Sabir Ali Siddique; Sajjad Ahmad; Souraya Goumri-Said
Journal:  Arab J Chem       Date:  2022-09-15       Impact factor: 6.212

2.  1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector Anopheles arabiensis and In Silico Molecular Docking Study.

Authors:  Katharigatta N Venugopala; Pottathil Shinu; Christophe Tratrat; Pran Kishore Deb; Raquel M Gleiser; Sandeep Chandrashekharappa; Deepak Chopra; Mahesh Attimarad; Anroop B Nair; Nagaraja Sreeharsha; Fawzi M Mahomoodally; Michelyne Haroun; Mahmoud Kandeel; Syed Mohammed Basheeruddin Asdaq; Viresh Mohanlall; Nizar A Al-Shar'i; Mohamed A Morsy
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

3.  Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.

Authors:  Katharigatta N Venugopala; G B Dharma Rao; Subhrajyoti Bhandary; Melendhran Pillay; Deepak Chopra; Bandar E Aldhubiab; Mahesh Attimarad; Osama Ibrahim Alwassil; Sree Harsha; Koleka Mlisana
Journal:  Drug Des Devel Ther       Date:  2016-08-25       Impact factor: 4.162

Review 4.  Recent synthetic and medicinal perspectives of dihydropyrimidinones: A review.

Authors:  Ramandeep Kaur; Sandeep Chaudhary; Kapil Kumar; Manish K Gupta; Ravindra K Rawal
Journal:  Eur J Med Chem       Date:  2017-03-19       Impact factor: 6.514

Review 5.  Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions.

Authors:  Francisco Sánchez-Sancho; Marcos Escolano; Daniel Gaviña; Aurelio G Csáky; María Sánchez-Roselló; Santiago Díaz-Oltra; Carlos Del Pozo
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-30

Review 6.  A mini-review on Biginelli adducts with notable pharmacological properties.

Authors:  Ângelo de Fátima; Taniris C Braga; Leonardo da S Neto; Bruna S Terra; Breno G F Oliveira; Daniel L da Silva; Luzia V Modolo
Journal:  J Adv Res       Date:  2014-11-01       Impact factor: 10.479

7.  In silico Design and Synthesis of Tetrahydropyrimidinones and Tetrahydropyrimidinethiones as Potential Thymidylate Kinase Inhibitors Exerting Anti-TB Activity Against Mycobacterium tuberculosis.

Authors:  Katharigatta N Venugopala; Christophe Tratrat; Melendhran Pillay; Sandeep Chandrashekharappa; Omar Husham Ahmed Al-Attraqchi; Bandar E Aldhubiab; Mahesh Attimarad; Osama I Alwassil; Anroop B Nair; Nagaraja Sreeharsha; Rashmi Venugopala; Mohamed A Morsy; Michelyne Haroun; Hezekiel M Kumalo; Bharti Odhav; Koleka Mlisana
Journal:  Drug Des Devel Ther       Date:  2020-03-09       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.